BILCARE RESEARCH OPENS NEW UNIT AT CRICKHOWELL
(Thomson Reuters ONE) -
11 March 2010 (Wales, UK) - Bilcare Global Clinical Supplies, a leading
single-source provider of clinical trial services spread across continents will
open its second unit on The Elvicta Industrial Estate, Crickhowell, Wales, UK.
The new unit will add 30,000 sq ft and double the company's European capacity to
package, store and distribute clinical supplies in ambient, refrigerated and
frozen conditions.
Bilcare - a global company headquartered in India - established its Crickhowell
site in 2006 when it purchased DHP. The Bilcare Global Clinical Supplies
facility at Crickhowell is contributing to a nascent pharmaceutical "cluster" of
companies in UK.
Mr. Mohan Bhandari, Chairman & Managing Director, Bilcare Limited, said, "With
the drug discovery program leading to potential new drugs becoming more complex,
the need to clinically test drug efficacy and safety in diverse population
groups across multiple geographic regions is becoming a crucial necessity. This
necessity has lead Bilcare to expand and open new facilities in US, Europe and
Asia. With this expansion of the second center at Crickhowell, we are now geared
to cater to ever challenging requirements of our global customers, especially
those part of the UK "cluster" of companies, looking to roll out their clinical
trials effectively in Europe."
Bilcare Global Clinical Supplies serves the Americas, Europe, and Asia with
clinical trial materials support, services and complete project management. Our
services for solid, semi-solid, liquid, DEA (CI-V) and biotech clinical trial
materials (CTM) satisfy a broad range of requirements, from pre-formulation
research and development, analytical services and clinical supplies packaging
and labeling, to IVRS, controlled temperature (cold and frozen chain) CTM
storage, distribution worldwide, and returns and destructions accountability.
For more information about Bilcare Global Clinical Supplies, please visit our
website at www.BilcareGCS.com
In conjunction with the expansion, Bilcare Research specializes in primary
packaging for pharmaceutical products and security technology such as
nonClonable(TM). Based around modular architecture, nonClonable(TM) enhances
customer safety, improves supply chain efficiency, reduces inventory levels, and
improves customer relationship management. Speaking on this new and innovative
technology, Dr. Praful Naik, Chief Scientific Officer, Bilcare Limited, said,
"This technology can help strengthen the secure pedigree of CTM globally across
clinical sites and provide multiple business outcomes i.e. effective & authentic
management of Returns, Reconciliation and Destruction."
Media Contacts:
Ian Morgan Jaydip Chowdhury
President Corporate Information Contact
Bilcare Global Clinical Supplies, Head Corporate Communications
Europe
Phone: +44 (0)1873-812182 Jaydip.Chowdhury(at)Bilcare.com
E-mail: Ian.Morgan(at)Bilcare.com
[HUG#1392771]
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.03.2010 - 03:01 Uhr
Sprache: Deutsch
News-ID 1011212
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Rajgurunagar
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 75 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BILCARE RESEARCH OPENS NEW UNIT AT CRICKHOWELL
"
steht unter der journalistisch-redaktionellen Verantwortung von
Bilcare Global Clinical Supplies (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
